Locally Advanced Pancreatic Ductal Adenocarcinoma Clinical Trials
20 clinical trials for Locally Advanced Pancreatic Ductal Adenocarcinoma across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma — RECRUITING · PHASE1
- A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer. — RECRUITING · PHASE1
- OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma — RECRUITING · PHASE1
- Targeted Pathway Inhibition in Patients With Pancreatic Cancer — RECRUITING · PHASE1
- Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment — RECRUITING · NA
- PULSAR in Systemic Therapy for Pancreatic Cancer — RECRUITING · PHASE2
- Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer — RECRUITING
- Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer — RECRUITING · NA
- A Study of GnP RegimenCombined With Serplulimab and Stereotactic Body Radiation Therapy as First-line Treatment for Locally Advanced Pancreatic Cancer — RECRUITING · PHASE2
- Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer — NOT_YET_RECRUITING · PHASE1
- Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Pancreatic Cancer — COMPLETED · PHASE1
- NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE1
- Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas. — COMPLETED · PHASE1
- New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study — WITHDRAWN · PHASE2
- STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma — WITHDRAWN · PHASE1
- Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer — ACTIVE_NOT_RECRUITING · PHASE1
- Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal Adenocarcinoma — COMPLETED · PHASE1
- FL118 for Treating Patients With Advanced Pancreatic Ductal Adenocarcinoma — WITHDRAWN · PHASE1
- AG Combined With Cadonilimab Sequential Short-course Radiotherapy in the Treatment of Locally aPDAC — OTHER · PHASE2
- Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma — WITHDRAWN · PHASE2
Refine this search